ConsiGma™ Wet Granulation and Tableting Line Installed at GEA’s test centre in Belgium
LEADING THE WAY GEA Group’s Pharma Systems division is leading the way in continuous processing technologies, backed up by the support of sister companies in other GEA Group divisions. Felicity Landon reports.
T
he pharmaceutical market is known for being highly regulated and therefor slow in adopting new technology – but technology leader GEA Group has been having some substantial success in introducing a radical new approach to the sector. GEA’s Pharma Systems division has led the way in the development and implementation of continuous processing and it continues to move forward with 216 Industry Europe
innovative solutions for its customers. Its ConsiGma™ continuous manufacturing platform includes a high shear granulation and drying system with a modular design ensuring plug flow, first-in first-out, avoiding back mixing, providing a consistent quality and allowing for critical quality control in-line. The most recent addition to the platform is a fully integrated continuous direct compression line.
The system allows for building quality into the process, to measure in-line and to adjust parameters to meet high-quality target levels. “Our achievements in continuous processing are getting a lot of attention – the pharmaceutical industry is usually slow in adopting radical new solutions, but it seems that we have developed something that, even in these times of slow growth, is attracting interest,” says Kris Schoeters, product manager con-
